{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:06:31Z","timestamp":1788926791447,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019693","name":"Universidade Federal Da Fronteira Sul","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03321-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:10:24Z","timestamp":1784088624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AC3\u00ae exerts cytotoxic and anti-migratory activity and modulates the gene expression of TNF-\u03b1, inflammatory mediators, and components of the CD39\/CD73\/adenosine axis in cutaneous melanoma cell lines"],"prefix":"10.1007","volume":"43","author":[{"given":"Daiane","family":"Manica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilnei Bruno","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Cristina","family":"Ozelame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit\u00f3ria Capelli","family":"de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Asmann","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Del Bosco Brunetti","family":"de Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniela Pinto","family":"Kempka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Zamoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete Dulce","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3321_CR1","doi-asserted-by":"publisher","unstructured":"Pan S-Y, Litscher G, Gao S-H, Zhou S-F, Yu Z-L, Chen H-Q et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Chan K, editor. Evid Based Complement Alternat Med. 2014;2014:525340. https:\/\/doi.org\/10.1155\/2014\/525340","DOI":"10.1155\/2014\/525340"},{"key":"3321_CR2","doi-asserted-by":"publisher","first-page":"102475","DOI":"10.1016\/j.arr.2024.102475","volume":"101","author":"Z Li","year":"2024","unstructured":"Li Z, Chen L, Qu L, Yu W, Liu T, Ning F, et al. Potential implications of natural compounds on aging and metabolic regulation. Ageing Res Rev. 2024;101:102475. https:\/\/doi.org\/10.1016\/j.arr.2024.102475.","journal-title":"Ageing Res Rev"},{"key":"3321_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13659-024-00445-z","volume":"14","author":"T Merenda","year":"2024","unstructured":"Merenda T, Juszczak F, Ferier E, Duez P, Patris S, Decl\u00e8ves A-\u00c9, et al. Natural Compounds Proposed for the Management of Non-Alcoholic Fatty Liver Disease. Nat Prod Bioprospecting. 2024;14:24. https:\/\/doi.org\/10.1007\/s13659-024-00445-z.","journal-title":"Nat Prod Bioprospecting"},{"key":"3321_CR4","doi-asserted-by":"publisher","first-page":"e35498","DOI":"10.1016\/j.heliyon.2024.e35498","volume":"10","author":"S Pezzino","year":"2024","unstructured":"Pezzino S, Sofia M, Mazzone C, Litrico G, Greco LP, Gallo L, et al. Innovative Treatments for Obesity and NAFLD: A Bibliometric Study on Antioxidants, Herbs, Phytochemicals, and Natural Compounds. Heliyon. 2024;10:e35498. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35498.","journal-title":"Heliyon"},{"key":"3321_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13205-024-03925-8","volume":"14","author":"P-T Nguyen-Thi","year":"2024","unstructured":"Nguyen-Thi P-T, Vo TK, Pham THT, Nguyen TT, Van Vo G. Natural Flavonoids as Potential Therapeutics in the Management of Alzheimer\u2019s Disease: A Review. 3 Biotech. 2024;14:68. https:\/\/doi.org\/10.1007\/s13205-024-03925-8.","journal-title":"3 Biotech"},{"key":"3321_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13167-022-00277-2","volume":"13","author":"A Mazurakova","year":"2022","unstructured":"Mazurakova A, Koklesova L, Samec M, Kudela E, Kajo K, Skuciova V, et al. Anti-Breast Cancer Effects of Phytochemicals: Primary, Secondary, and Tertiary Care. EPMA J. 2022;13:315\u201334. https:\/\/doi.org\/10.1007\/s13167-022-00277-2.","journal-title":"EPMA J"},{"key":"3321_CR7","doi-asserted-by":"publisher","unstructured":"Nagar A, Dubey A, Sharma A, Singh M. Exploring promising natural compounds for breast cancer treatment: in silico molecular docking targeting WDR5-MYC protein interaction. J Biomol Struct Dyn. 2024;1\u201315. https:\/\/doi.org\/10.1080\/07391102.2024.2317975.","DOI":"10.1080\/07391102.2024.2317975"},{"key":"3321_CR8","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/cancers14246203","volume":"14","author":"ST Asma","year":"2022","unstructured":"Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, et al. Natural Products\/Bioactive Compounds as a Source of Anticancer Drugs. Cancers. 2022;14:6203. https:\/\/doi.org\/10.3390\/cancers14246203.","journal-title":"Cancers"},{"key":"3321_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.bcp.2008.08.008","volume":"76","author":"P Anand","year":"2008","unstructured":"Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, et al. Biological Activities of Curcumin and Its Analogues (Congeners) Made by Man and Mother Nature. Biochem Pharmacol. 2008;76:1590\u2013611. https:\/\/doi.org\/10.1016\/j.bcp.2008.08.008.","journal-title":"Biochem Pharmacol"},{"key":"3321_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.7150\/ijbs.80590","volume":"19","author":"K-H Lu","year":"2023","unstructured":"Lu K-H, Lu PW-A, Lu EW-H, Lin C-W, Yang S-F. Curcumin and Its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma. Int J Biol Sci. 2023;19:1241\u201365. https:\/\/doi.org\/10.7150\/ijbs.80590.","journal-title":"Int J Biol Sci"},{"key":"3321_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ptr.5030","volume":"28","author":"T Ahmed","year":"2014","unstructured":"Ahmed T, Gilani A-H. Therapeutic Potential of Turmeric in Alzheimer\u2019s Disease: Curcumin or Curcuminoids? Phytother Res. 2014;28:517\u201325. https:\/\/doi.org\/10.1002\/ptr.5030.","journal-title":"Phytother Res"},{"key":"3321_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/carcin\/bgm123","volume":"28","author":"SK Sandur","year":"2007","unstructured":"Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, et al. Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin, Tetrahydrocurcumin and Turmerones Differentially Regulate Anti-Inflammatory and Anti-Proliferative Responses through a ROS-Independent Mechanism. Carcinogenesis. 2007;28:1765\u201373. https:\/\/doi.org\/10.1093\/carcin\/bgm123.","journal-title":"Carcinogenesis"},{"key":"3321_CR13","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1021\/acs.jafc.4c11101","volume":"73","author":"K-Y Hsu","year":"2025","unstructured":"Hsu K-Y, Majeed A, Ho C-T, Pan M-H. Bisdemethoxycurcumin and Curcumin Alleviate Inflammatory Bowel Disease by Maintaining Intestinal Epithelial Integrity and Regulating Gut Microbiota in Mice. J Agric Food Chem. 2025;73:3494\u2013506. https:\/\/doi.org\/10.1021\/acs.jafc.4c11101.","journal-title":"J Agric Food Chem"},{"key":"3321_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/jpp\/rgab028","volume":"73","author":"S Thanawala","year":"2021","unstructured":"Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative Bioavailability of Curcuminoids from a Water-Dispersible High Curcuminoid Turmeric Extract against a Generic Turmeric Extract: A Randomized, Cross-over, Comparative, Pharmacokinetic Study. J Pharm Pharmacol. 2021;73:816\u201323. https:\/\/doi.org\/10.1093\/jpp\/rgab028.","journal-title":"J Pharm Pharmacol"},{"key":"3321_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.biopha.2015.07.024","volume":"74","author":"K Mohankumar","year":"2015","unstructured":"Mohankumar K, Sridharan S, Pajaniradje S, Singh VK, Ronsard L, Banerjea AC, et al. BDMC-A, an Analog of Curcumin, Inhibits Markers of Invasion, Angiogenesis, and Metastasis in Breast Cancer Cells via NF-\u03baB Pathway\u2014A Comparative Study with Curcumin. Biomed Pharmacother. 2015;74:178\u201386. https:\/\/doi.org\/10.1016\/j.biopha.2015.07.024.","journal-title":"Biomed Pharmacother"},{"key":"3321_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12906-020-2857-1","volume":"20","author":"C Huang","year":"2020","unstructured":"Huang C, Lu H-F, Chen Y-H, Chen J-C, Chou W-H, Huang H-C. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and \u2013independent apoptosis via Smad or Akt signaling pathways in HOS cells. BMC Complement Med Ther. 2020;20:68. https:\/\/doi.org\/10.1186\/s12906-020-2857-1.","journal-title":"BMC Complement Med Ther"},{"key":"3321_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European Consensus-Based Interdisciplinary Guideline for Melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022;170:236\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008.","journal-title":"Eur J Cancer"},{"key":"3321_CR18","doi-asserted-by":"publisher","first-page":"101042831983713","DOI":"10.1177\/1010428319837138","volume":"41","author":"A Passarelli","year":"2019","unstructured":"Passarelli A, Tucci M, Mannavola F, Felici C, Silvestris F. The Metabolic Milieu in Melanoma: Role of Immune Suppression by CD73\/Adenosine. Tumor Biol. 2019;41:1010428319837138. https:\/\/doi.org\/10.1177\/1010428319837138.","journal-title":"Tumor Biol"},{"key":"3321_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11302-024-10002-5","volume":"20","author":"G De Carvalho Braga","year":"2024","unstructured":"De Carvalho Braga G, Coiado JV, De Melo VC, Loureiro BB, Bagatini MD. Cutaneous melanoma and purinergic modulation by phenolic compounds. Purinergic Signal. 2024;20:581\u201393. https:\/\/doi.org\/10.1007\/s11302-024-10002-5.","journal-title":"Purinergic Signal"},{"key":"3321_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-024-10023-0","author":"D Manica","year":"2024","unstructured":"Manica D, Da Silva GB, Narzetti RA, Dallagnoll P, Da Silva AP, Marafon F, et al. Curcumin Modulates Purinergic Signaling and Inflammatory Response in Cutaneous Metastatic Melanoma Cells. Purinergic Signal. 2024. https:\/\/doi.org\/10.1007\/s11302-024-10023-0.","journal-title":"Purinergic Signal"},{"key":"3321_CR21","doi-asserted-by":"publisher","first-page":"26659","DOI":"10.18632\/oncotarget.25426","volume":"9","author":"I Monteiro","year":"2018","unstructured":"Monteiro I, Vigano S, Faouzi M, Treilleux I, Michielin O, M\u00e9n\u00e9trier-Caux C, et al. CD73 Expression and Clinical Significance in Human Metastatic Melanoma. Oncotarget. 2018;9:26659\u201369. https:\/\/doi.org\/10.18632\/oncotarget.25426.","journal-title":"Oncotarget"},{"key":"3321_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","volume":"9","author":"G Burnstock","year":"2013","unstructured":"Burnstock G, Di Virgilio F. Purinergic signalling and cancer. Purinergic Signal. 2013;9:491\u2013540. https:\/\/doi.org\/10.1007\/s11302-013-9372-5.","journal-title":"Purinergic Signal"},{"key":"3321_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J Immunol Methods. 1983;65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"key":"3321_CR24","doi-asserted-by":"publisher","unstructured":"McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, et al. Chapter 9 The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol [Internet] Elsevier. 1995;153\u201385. https:\/\/doi.org\/10.1016\/S0091-679X(08)61929-9. [cited 2025 Jan 10].","DOI":"10.1016\/S0091-679X(08)61929-9"},{"key":"3321_CR25","doi-asserted-by":"publisher","unstructured":"Joshi DC, Bakowska JC. Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons. J Vis Exp. 2011;2704. https:\/\/doi.org\/10.3791\/2704.","DOI":"10.3791\/2704"},{"key":"3321_CR26","doi-asserted-by":"publisher","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014;51046. https:\/\/doi.org\/10.3791\/51046.","DOI":"10.3791\/51046"},{"key":"3321_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/cbf.3863","volume":"41","author":"D Manica","year":"2023","unstructured":"Manica D, Silva GBD, Silva APD, Marafon F, Maciel SFVDO, Bagatini MD, et al. Curcumin promotes apoptosis of human melanoma cells by caspase 3. Cell Biochem Funct. 2023;41:1295\u2013304. https:\/\/doi.org\/10.1002\/cbf.3863.","journal-title":"Cell Biochem Funct"},{"key":"3321_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT Method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"3321_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/09537109609023582","volume":"7","author":"C Pilla","year":"1996","unstructured":"Pilla C, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF. ATP Diphosphohydrolase Activity (Apyrase, EC 3.6.1.5) in Human Blood Platelets. Platelets. 1996;7:225\u201330. https:\/\/doi.org\/10.3109\/09537109609023582.","journal-title":"Platelets"},{"key":"3321_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0049-3848(03)00178-6","volume":"109","author":"GI Lunkes","year":"2003","unstructured":"Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, et al. Enzymes That Hydrolyze Adenine Nucleotides in Diabetes and Associated Pathologies. Thromb Res. 2003;109:189\u201394. https:\/\/doi.org\/10.1016\/S0049-3848(03)00178-6.","journal-title":"Thromb Res"},{"key":"3321_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11302-023-09967-6","volume":"20","author":"D Manica","year":"2024","unstructured":"Manica D, Da Silva GB, De Lima J, Cassol J, Dallagnol P, Narzetti RA, et al. Caffeine reduces viability, induces apoptosis, inhibits migration and modulates the CD39\/CD73 axis in metastatic cutaneous melanoma cells. Purinergic Signal. 2024;20:385\u201397. https:\/\/doi.org\/10.1007\/s11302-023-09967-6.","journal-title":"Purinergic Signal"},{"key":"3321_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal Biochem. 1976;72:248\u201354. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3.","journal-title":"Anal Biochem"},{"key":"3321_CR33","doi-asserted-by":"publisher","first-page":"114689","DOI":"10.1016\/j.jep.2021.114689","volume":"283","author":"M Li","year":"2022","unstructured":"Li M, Guo T, Lin J, Huang X, Ke Q, Wu Y, et al. Curcumin Inhibits the Invasion and Metastasis of Triple Negative Breast Cancer via Hedgehog\/Gli1 Signaling Pathway. J Ethnopharmacol. 2022;283:114689. https:\/\/doi.org\/10.1016\/j.jep.2021.114689.","journal-title":"J Ethnopharmacol"},{"key":"3321_CR34","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1080\/01635581.2022.2049321","volume":"74","author":"M Mohamadian","year":"2022","unstructured":"Mohamadian M, Bahrami A, Moradi Binabaj M, Asgharzadeh F, Ferns GA. Molecular Targets of Curcumin and Its Therapeutic Potential for Ovarian Cancer. Nutr Cancer. 2022;74:2713\u201330. https:\/\/doi.org\/10.1080\/01635581.2022.2049321.","journal-title":"Nutr Cancer"},{"key":"3321_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.26355\/eurrev_201801_14209","volume":"22","author":"B-Z Zheng","year":"2018","unstructured":"Zheng B-Z, Liu T-D, Chen G, Zhang J-X, Kang X. The Effect of Curcumin on Cell Adhesion of Human Esophageal Cancer Cell. Eur Rev Med Pharmacol Sci. 2018;22:551\u201360. https:\/\/doi.org\/10.26355\/eurrev_201801_14209.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3321_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.55730\/1300-0144.5652","volume":"53","author":"Z Dal","year":"2023","unstructured":"Dal Z, Aru B. The Role of Curcumin on Apoptosis and NLRP3 Inflammasome-Dependent Pyroptosis on Colorectal Cancer in Vitro. Turk J Med Sci. 2023;53:883\u201393. https:\/\/doi.org\/10.55730\/1300-0144.5652.","journal-title":"Turk J Med Sci"},{"key":"3321_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","volume":"43","author":"D Yang","year":"2015","unstructured":"Yang D, He Y, Mu\u00f1oz-Planillo R, Liu Q, N\u00fa\u00f1ez G. Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. Immunity. 2015;43:923\u201332. https:\/\/doi.org\/10.1016\/j.immuni.2015.10.009.","journal-title":"Immunity"},{"key":"3321_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/or.2015.4413","volume":"35","author":"G Zhao","year":"2016","unstructured":"Zhao G, Han X, Zheng S, Li Z, Sha Y, Ni J, et al. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT\/mTOR signaling pathway in human melanoma cells. Oncol Rep. 2016;35:1065\u201374. https:\/\/doi.org\/10.3892\/or.2015.4413.","journal-title":"Oncol Rep"},{"key":"3321_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2014.04.024","volume":"448","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Yu T, Wang W, Pan K, Shi D, Sun H. Curcumin-Induced Melanoma Cell Death Is Associated with Mitochondrial Permeability Transition Pore (mPTP) Opening. Biochem Biophys Res Commun. 2014;448:15\u201321. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.024.","journal-title":"Biochem Biophys Res Commun"},{"key":"3321_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/02713680903521944","volume":"35","author":"C Lu","year":"2010","unstructured":"Lu C, Song E, Hu D-N, Chen M, Xue C, Rosen R, et al. Curcumin Induces Cell Death in Human Uveal Melanoma Cells through Mitochondrial Pathway. Curr Eye Res. 2010;35:352\u201360. https:\/\/doi.org\/10.3109\/02713680903521944.","journal-title":"Curr Eye Res"},{"key":"3321_CR41","doi-asserted-by":"publisher","unstructured":"Jeon H-J, Kim K, Kim C, Lee S-E. Antimelanogenic Effects of curcumin and its dimethoxy derivatives: mechanistic investigation using B16F10 melanoma cells and zebrafish (Danio rerio) embryos. Foods. Basel, Switzerland; 2023;12:926. https:\/\/doi.org\/10.3390\/foods12050926","DOI":"10.3390\/foods12050926"},{"key":"3321_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10495-017-1395-x","volume":"22","author":"H-J Wang","year":"2017","unstructured":"Wang H-J, Yang Z-X, Dai X-T, Chen Y-F, Yang H-P, Zhou X-D. Bisdemethoxycurcumin Sensitizes Cisplatin-Resistant Lung Cancer Cells to Chemotherapy by Inhibition of CA916798 and PI3K\/AKT Signaling. Apoptosis. 2017;22:1157\u201368. https:\/\/doi.org\/10.1007\/s10495-017-1395-x.","journal-title":"Apoptosis"},{"key":"3321_CR43","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.21873\/anticanres.12686","volume":"38","author":"C-L Liao","year":"2018","unstructured":"Liao C-L, Chu Y-L, Lin H-Y, Chen C-Y, Hsu M-J, Liu K-C, et al. Bisdemethoxycurcumin Suppresses Migration and Invasion of Human Cervical Cancer HeLa Cells via Inhibition of NF-\u03baB, MMP-2 and \u2013\u20099 Pathways. Anticancer Res. 2018;38:3989\u201397. https:\/\/doi.org\/10.21873\/anticanres.12686.","journal-title":"Anticancer Res"},{"key":"3321_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3729399","volume":"2023","author":"M Majeed","year":"2023","unstructured":"Majeed M, Bani S, Pandey A, Ibrahim AM, Thazhathidath S. Assessment of Safety Profile of Activated Curcumin C3 Complex (AC3), Enriched Extract of Bisdemethoxycurcumin from the Rhizomes of Curcuma Longa. J Toxicol. 2023;2023:1\u201318. https:\/\/doi.org\/10.1155\/2023\/3729399.","journal-title":"J Toxicol"},{"key":"3321_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13046-018-0982-1","volume":"37","author":"S Rossi","year":"2018","unstructured":"Rossi S, Cordella M, Tabolacci C, Nassa G, D\u2019Arcangelo D, Senatore C, et al. TNF-Alpha and Metalloproteases as Key Players in Melanoma Cells Aggressiveness. J Exp Clin Cancer Res. 2018;37:326. https:\/\/doi.org\/10.1186\/s13046-018-0982-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"3321_CR46","doi-asserted-by":"publisher","first-page":"e20511225611","DOI":"10.33448\/rsd-v11i2.25611","volume":"11","author":"VL Lunkes","year":"2022","unstructured":"Lunkes VL, Palma TV, Mostardeiro VB, Mastella MH, Assmann CE, Pillat MM, et al. Curcumin and Vinblastine Induce Apoptosis and Impair Migration in Human Cutaneous Melanoma Cells. Res Soc Dev. 2022;11:e20511225611. https:\/\/doi.org\/10.33448\/rsd-v11i2.25611.","journal-title":"Res Soc Dev"},{"key":"3321_CR47","doi-asserted-by":"publisher","first-page":"110883","DOI":"10.1016\/j.biopha.2020.110883","volume":"132","author":"W Szlasa","year":"2020","unstructured":"Szlasa W, Supplitt S, Dr\u0105g-Zalesi\u0144ska M, Przystupski D, Kotowski K, Szewczyk A, et al. Effects of Curcumin Based PDT on the Viability and the Organization of Actin in Melanotic (A375) and Amelanotic Melanoma (C32) \u2013 in Vitro Studies. Biomed Pharmacother. 2020;132:110883. https:\/\/doi.org\/10.1016\/j.biopha.2020.110883.","journal-title":"Biomed Pharmacother"},{"key":"3321_CR48","doi-asserted-by":"publisher","first-page":"127600","DOI":"10.1016\/j.molliq.2025.127600","volume":"429","author":"L Schlichting","year":"2025","unstructured":"Schlichting L, Valentini G, Santos BM, Sanches MP, Soares RV, Saatkamp RH, et al. Chitosan\/Hydroxypropyl Methylcellulose Acetate Succinate Nanoparticles as a Promising Delivery System for Curcumin in MDA-MB-231 Breast Cancer Cells. J Mol Liq. 2025;429:127600. https:\/\/doi.org\/10.1016\/j.molliq.2025.127600.","journal-title":"J Mol Liq"},{"key":"3321_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14715\/cmb\/2017.63.11.17","volume":"63","author":"A Kocyigit","year":"2017","unstructured":"Kocyigit A, Guler EM, Curcumin Induce DNA. Damage and Apoptosis through Generation of Reactive Oxygen Species and Reducing Mitochondrial Membrane Potential in Melanoma Cancer Cells. Cell Mol Biol. 2017;63:97\u2013105. https:\/\/doi.org\/10.14715\/cmb\/2017.63.11.17.","journal-title":"Cell Mol Biol"},{"key":"3321_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.biopha.2017.09.026","volume":"95","author":"W Liao","year":"2017","unstructured":"Liao W, Xiang W, Wang F-F, Wang R, Ding Y. Curcumin Inhibited Growth of Human Melanoma A375 Cells via Inciting Oxidative Stress. Biomed Pharmacother. 2017;95:1177\u201386. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.026.","journal-title":"Biomed Pharmacother"},{"key":"3321_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1039\/c5fo00681c","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu R, et al. Induction of ROS-independent DNA damage by curcumin leads to G2\/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells. Food Funct. 2016;7:315\u201325. https:\/\/doi.org\/10.1039\/c5fo00681c.","journal-title":"Food Funct"},{"key":"3321_CR52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.yexcr.2009.12.011","volume":"316","author":"Z Mahmood","year":"2010","unstructured":"Mahmood Z, Shukla Y. Death Receptors: Targets for Cancer Therapy. Exp Cell Res. 2010;316:887\u201399. https:\/\/doi.org\/10.1016\/j.yexcr.2009.12.011.","journal-title":"Exp Cell Res"},{"key":"3321_CR53","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","volume":"37","author":"Y Kiraz","year":"2016","unstructured":"Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biol. 2016;37:8471\u201386. https:\/\/doi.org\/10.1007\/s13277-016-5035-9.","journal-title":"Tumor Biol"},{"key":"3321_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12885-021-08237-1","volume":"21","author":"S Tyciakova","year":"2021","unstructured":"Tyciakova S, Valova V, Svitkova B, Matuskova M. Overexpression of TNF\u03b1 Induces Senescence, Autophagy and Mitochondrial Dysfunctions in Melanoma Cells. BMC Cancer. 2021;21:507. https:\/\/doi.org\/10.1186\/s12885-021-08237-1.","journal-title":"BMC Cancer"},{"key":"3321_CR55","first-page":"176","volume":"34","author":"AR Safa","year":"2012","unstructured":"Safa AR. c-FLIP, a Master Anti-Apoptotic Regulator. Exp Oncol. 2012;34:176\u201384.","journal-title":"Exp Oncol"},{"key":"3321_CR56","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1111\/febs.14523","volume":"285","author":"L Humphreys","year":"2018","unstructured":"Humphreys L, Espona-Fiedler M, Longley DB. FLIP as a Therapeutic Target in Cancer. FEBS J. 2018;285:4104\u201323. https:\/\/doi.org\/10.1111\/febs.14523.","journal-title":"FEBS J"},{"key":"3321_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1158\/0008-5472.CAN-06-1880","volume":"67","author":"VC Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer VC, Karasarides M, Hayward R, Marais R. Tumor Necrosis Factor-\u03b1 Blocks Apoptosis in Melanoma Cells When BRAF Signaling Is Inhibited. Cancer Res. 2007;67:122\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1880.","journal-title":"Cancer Res"},{"key":"3321_CR58","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/jid.2015.91","volume":"135","author":"J Zhang","year":"2015","unstructured":"Zhang J, Chen Y, Huang Q. others. NF\u03baB Regulation of c-FLIP Promotes TNF\u03b1-Mediated RAF-Inhibitor Resistance in Melanoma. J Invest Dermatol. 2015;135:1839\u201348. https:\/\/doi.org\/10.1038\/jid.2015.91.","journal-title":"J Invest Dermatol"},{"key":"3321_CR59","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, Zeiser R. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword. Front Immunol. 2020;11:1444. https:\/\/doi.org\/10.3389\/fimmu.2020.01444.","journal-title":"Front Immunol"},{"key":"3321_CR60","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1158\/0008-5472.CAN-10-1921","volume":"70","author":"HW Van Deventer","year":"2010","unstructured":"Van Deventer HW, Burgents JE, Wu QP, Woodford R-MT, Brickey WJ, Allen IC, et al. The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells. Cancer Res. 2010;70:10161\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1921.","journal-title":"Cancer Res"},{"key":"3321_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2011.10.001","volume":"314","author":"JH Dunn","year":"2012","unstructured":"Dunn JH, Ellis LZ, Fujita M. Inflammasomes as Molecular Mediators of Inflammation and Cancer: Potential Role in Melanoma. Cancer Lett. 2012;314:24\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2011.10.001.","journal-title":"Cancer Lett"},{"key":"3321_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.17352","volume":"182","author":"N Pazhouhesh Far","year":"2025","unstructured":"Pazhouhesh Far N, Hajiheidari Varnousafaderani M, Faghihkhorasani F, Etemad S, Abdulwahid ARR, Bakhtiarinia N, et al. Breaking the Barriers: Overcoming Cancer Resistance by Targeting the NLRP3 Inflammasome. Br J Pharmacol. 2025;182:3\u201325. https:\/\/doi.org\/10.1111\/bph.17352.","journal-title":"Br J Pharmacol"},{"key":"3321_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG. Nucleotide- and Nucleoside-Converting Ectoenzymes: Important Modulators of Purinergic Signalling Cascade. Biochim Biophys Acta BBA -. Mol Cell Res. 2008;1783:673\u201394. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.024.","journal-title":"Mol Cell Res"},{"key":"3321_CR64","doi-asserted-by":"publisher","first-page":"2105376","DOI":"10.1002\/advs.202105376","volume":"9","author":"L Wu","year":"2022","unstructured":"Wu L, Xie W, Li Y, Ni Q, Timashev P, Lyu M, et al. Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System. Adv Sci. 2022;9:2105376. https:\/\/doi.org\/10.1002\/advs.202105376.","journal-title":"Adv Sci"},{"key":"3321_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors\u2014An Update. Pharmacol Rev. 2011;63:1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285.","journal-title":"Pharmacol Rev"},{"key":"3321_CR66","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","volume":"36","author":"D Boison","year":"2019","unstructured":"Boison D, Yegutkin GG. Adenosine Metabolism: Emerging Concepts for Cancer Therapy. Cancer Cell. 2019;36:582\u201396. https:\/\/doi.org\/10.1016\/j.ccell.2019.10.007.","journal-title":"Cancer Cell"},{"key":"3321_CR67","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting Immunogenic Cell Death in Cancer. Mol Oncol. 2020;14:2994\u20133006. https:\/\/doi.org\/10.1002\/1878-0261.12851.","journal-title":"Mol Oncol"},{"key":"3321_CR68","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL, Smyth MJ. Targeting Immunosuppressive Adenosine in Cancer. Nat Rev Cancer. 2017;17:709\u201324. https:\/\/doi.org\/10.1038\/nrc.2017.86.","journal-title":"Nat Rev Cancer"},{"key":"3321_CR69","doi-asserted-by":"publisher","first-page":"102499","DOI":"10.1016\/j.ctrv.2022.102499","volume":"113","author":"DC Ziogas","year":"2023","unstructured":"Ziogas DC, Theocharopoulos C, Koutouratsas T, Haanen J, Gogas H. Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma: What We Have to Overcome? Cancer Treat Rev. 2023;113:102499. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102499.","journal-title":"Cancer Treat Rev"},{"key":"3321_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L. CD39\/CD73\/A2AR Pathway and Cancer Immunotherapy. Mol Cancer. 2023;22:44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x.","journal-title":"Mol Cancer"},{"key":"3321_CR71","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/ijo.2016.3598","volume":"49","author":"M Gallardo","year":"2016","unstructured":"Gallardo M, Calaf GM. Curcumin Inhibits Invasive Capabilities through Epithelial Mesenchymal Transition in Breast Cancer Cell Lines. Int J Oncol. 2016;49:1019\u201327. https:\/\/doi.org\/10.3892\/ijo.2016.3598.","journal-title":"Int J Oncol"},{"key":"3321_CR72","doi-asserted-by":"publisher","first-page":"117033","DOI":"10.1016\/j.biopha.2024.117033","volume":"177","author":"C Giraulo","year":"2024","unstructured":"Giraulo C, Orlando L, Morretta E, Voli A, Plaitano P, Cicala C, et al. High Levels of Soluble CD73 Unveil Resistance to BRAF Inhibitors in Melanoma Cells. Biomed Pharmacother. 2024;177:117033. https:\/\/doi.org\/10.1016\/j.biopha.2024.117033.","journal-title":"Biomed Pharmacother"},{"key":"3321_CR73","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics13050706","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang A, Gupte AA, Hamilton DJ. Plumbagin Elicits Cell-Specific Cytotoxic Effects and Metabolic Responses in Melanoma Cells. Pharmaceutics. 2021;13:706. https:\/\/doi.org\/10.3390\/pharmaceutics13050706.","journal-title":"Pharmaceutics"},{"key":"3321_CR74","doi-asserted-by":"publisher","first-page":"115225","DOI":"10.1016\/j.biopha.2023.115225","volume":"165","author":"C Giraulo","year":"2023","unstructured":"Giraulo C, Turiello R, Orlando L, Leonardelli S, Landsberg J, Belvedere R, et al. The CD73 Is Induced by TGF-\u03b21 Triggered by Nutrient Deprivation and Highly Expressed in Dedifferentiated Human Melanoma. Biomed Pharmacother. 2023;165:115225. https:\/\/doi.org\/10.1016\/j.biopha.2023.115225.","journal-title":"Biomed Pharmacother"},{"key":"3321_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The Ectonucleotidases CD39 and CD73: Novel Checkpoint Inhibitor Targets. Immunol Rev. 2017;276:121\u201344. https:\/\/doi.org\/10.1111\/imr.12528.","journal-title":"Immunol Rev"},{"key":"3321_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biochi.2020.06.001","volume":"176","author":"A Soleimani","year":"2020","unstructured":"Soleimani A, Farshchi HK, Mirzavi F, Zamani P, Ghaderi A, Amini Y, et al. The Therapeutic Potential of Targeting CD73 and CD73-Derived Adenosine in Melanoma. Biochimie. 2020;176:21\u201330. https:\/\/doi.org\/10.1016\/j.biochi.2020.06.001.","journal-title":"Biochimie"},{"key":"3321_CR77","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune Checkpoint Inhibitors in Melanoma. Lancet. 2021;398:1002\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(21)01206-X.","journal-title":"Lancet"},{"key":"3321_CR78","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob J-J, Rutkowski P, Lao CD, et al. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. N Engl J Med. 2019;381:1535\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1910836.","journal-title":"N Engl J Med"},{"key":"3321_CR79","doi-asserted-by":"publisher","first-page":"e142843","DOI":"10.1172\/jci.insight.142843","volume":"7","author":"E Tu","year":"2022","unstructured":"Tu E, McGlinchey K, Wang J, Martin P, Ching SLK, Floc\u2019h N, et al. Anti\u2013PD-L1 and Anti-CD73 Combination Therapy Promotes T Cell Response to EGFR-Mutated NSCLC. JCI Insight. 2022;7:e142843. https:\/\/doi.org\/10.1172\/jci.insight.142843.","journal-title":"JCI Insight"},{"key":"3321_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389. https:\/\/doi.org\/10.1038\/s41577-019-0165-0.","journal-title":"Nat Rev Immunol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03321-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:21:45Z","timestamp":1788924105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":80,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["3321"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03321-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used the tool Claude, version Opus 4.8, developed by Anthropic, for grammar review and restructuring of ideas. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the final content of the publication.","order":2,"name":"Ethics","label":"Declaration of IA use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}